ArticleTropical animal health and production2021
Clinico-molecular diagnosis and characterization of bovine lumpy skin disease virus in Andhra Pradesh, India.
Article in Tropical animal health and production, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Lumpy Skin Disease in Cattle and Buffalo in Asian Countries: A Systematic Review and Meta-Analysis.Veterinary medicine and science · 2025Pooled it
- Epidemiology of lumpy skin disease in Northeast India and a new method for rapid field diagnosis.AMB Express · 2025Article
- Clinical and molecular description of natural infections with an Asian strain of lumpy skin disease virus in Bos indicus.Scientific reports · 2025Article
- Molecular epidemiological and spatiotemporal analysis of lumpy skin disease outbreaks in cattle from Karnataka, India.Frontiers in cellular and infection microbiology · 2025Article
- Lumpy Skin Disease: Insights into Molecular Pathogenesis and Control Strategies.Veterinary sciences · 2024Review
- Article
- Understanding the research advances on lumpy skin disease: A comprehensive literature review of experimental evidence.Frontiers in microbiology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lumpy skin disease (LSD) is an emerging transboundary disease in India. In the recent past, Andhra Pradesh is experiencing outbreaks of LSD in several pockets with a severe economic impact on the farming community. The affected animals showed nodular lesions all over the body in severely affected cases, whereas the lesions were confined to the face, neck, jowl, back, udder, and scrotum in less affected cases. Young ones are highly susceptible to the disease than adults. The mortality was found to be more in young ones than adult cattle which might be due to subsequent secondary bacterial complications. Clinical samples like blood, serum, and tissues were collected randomly from affected animals from four different pockets of Andhra Pradesh. The tissue samples gave positive amplification in PCR targeting LSDV fusion protein gene (ORF 117) and yielded 472 bp product. Another gene specifically targeting ORF036 of LSDV also gave amplification in tissue samples with a product size of 606 bp. The representative samples from four different regions were sequenced for ORF 117 and 036 genes. The phylogeny of the sequenced products of ORF 117 showed more similarity with Kenya Neethling 2490 strain and Russian isolates of 2019. In addition, the phylogeny of ORF 036 showed the path of entry of the virus into the country and also to Andhra Pradesh. The isolates showed similarity with the isolates of India (Odisha), Bangladesh, Russia, Egypt, and Kenya. These studies paved way for the future perspective of developing a vaccine to control the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.